Viewing Study NCT01738867


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2026-02-06 @ 8:03 PM
Study NCT ID: NCT01738867
Status: COMPLETED
Last Update Posted: 2017-05-10
First Post: 2012-11-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alcoholism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Pharmacogenetics View
None OPRM1 View
None Pharmacodynamics View
None Addiction View
None mu opioid receptors View